Addressing the Challenges of Translating LRRK2 Biology into Disease-Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange Initiative.

Sammler E, Tonelli F, Durborow M, McNasby J, Sherer T, Ahmed M, Djuric SW, Merchant K, Reith A, Schoepp D, Klein C, Padmanabhan S, Alessi DR

Open source

DOI: 10.1002/mds.70397
Published: 2026 Sep
Container: Movement disorders : official journal of the Movement Disorder Society
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/mds.70397,
  title = {Addressing the Challenges of Translating LRRK2 Biology into Disease-Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange Initiative.},
  author = {Sammler E and Tonelli F and Durborow M and McNasby J and Sherer T and Ahmed M and Djuric SW and Merchant K and Reith A and Schoepp D and Klein C and Padmanabhan S and Alessi DR},
  year = {2026},
  journal = {Movement disorders : official journal of the Movement Disorder Society},
  doi = {10.1002/mds.70397},
  url = {https://doi.org/10.1002/mds.70397}
}

RIS

TY  - JOUR
TI  - Addressing the Challenges of Translating LRRK2 Biology into Disease-Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange Initiative.
AU  - Sammler E
AU  - Tonelli F
AU  - Durborow M
AU  - McNasby J
AU  - Sherer T
AU  - Ahmed M
AU  - Djuric SW
AU  - Merchant K
AU  - Reith A
AU  - Schoepp D
AU  - Klein C
AU  - Padmanabhan S
AU  - Alessi DR
PY  - 2026
JO  - Movement disorders : official journal of the Movement Disorder Society
DO  - 10.1002/mds.70397
UR  - https://doi.org/10.1002/mds.70397
ER  -

APA

E, S., F, T., M, D., J, M., T, S., M, A., SW, D., K, M., A, R., D, S., C, K., S, P., & DR, A. (2026). Addressing the Challenges of Translating LRRK2 Biology into Disease-Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange Initiative.. Movement disorders : official journal of the Movement Disorder Society. https://doi.org/10.1002/mds.70397

Source records

pubmed · retrieved 2026-09-25T22:42:01.092Z